Literature DB >> 9481543

Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome.

M G van Pampus1, H Wolf, S M Westenberg, J A van der Post, G J Bonsel, P E Treffers.   

Abstract

OBJECTIVE: To compare maternal and perinatal outcome of pregnancies complicated by pregnancy induced hypertension and HELLP syndrome with the outcome of pregnancies complicated by pre-eclampsia only.
DESIGN: It was a retrospective cohort study. Fifty one patients with pregnancy induced hypertension and HELLP syndrome were matched with 51 pre-eclamptic patients according to parity and gestational age on admission in hospital. Management was expectant, treatment only symptomatic and delivery was mainly effectuated because of fetal condition.
RESULTS: There was no maternal mortality in either group; maternal morbidity was more frequent in the HELLP group. Immediate intervention within a few hours of admission because of fetal distress more often occurred in the HELLP group. In both groups 41 children (80%) are still alive, with one major handicapped child in each group. Logistic regression analysis identified gestational age on admission and antihypertensive treatment on admission as significant contributors to perinatal mortality or major handicap. Whether the patient belonged to the HELLP group or the pre-eclamptic group had no influence on outcome.
CONCLUSION: Expectant management of pregnancy induced hypertension with HELLP syndrome and pre-eclampsia without HELLP syndrome results in similar maternal and perinatal outcome. Perinatal outcome is strongly influenced by gestational age and the severity of hypertension as expressed by the need of antihypertensive treatment, irrespective of the underlying syndrome.

Entities:  

Mesh:

Year:  1998        PMID: 9481543     DOI: 10.1016/s0301-2115(97)00146-2

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  7 in total

1.  Comparison of maternal and neonatal outcomes in women with HELLP syndrome and women with severe preeclampsia without HELLP syndrome.

Authors:  Abdulkadir Turgut; Oya Demirci; Elif Demirci; Mehmet Uludoğan
Journal:  J Prenat Med       Date:  2010-07

2.  Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Heather A Drummond; Babbette LaMarca; Michael J Ryan; Joey P Granger
Journal:  Compr Physiol       Date:  2020-12-09       Impact factor: 9.090

Review 3.  Treating hypertension in women of child-bearing age and during pregnancy.

Authors:  L A Magee
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

5.  Neonatal outcome after preterm delivery in HELLP syndrome.

Authors:  Hye Yeon Kim; Yong Seok Sohn; Jae Hak Lim; Euy Hyuk Kim; Ja Young Kwon; Yong Won Park; Young Han Kim
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

Review 6.  The HELLP syndrome: clinical issues and management. A Review.

Authors:  Kjell Haram; Einar Svendsen; Ulrich Abildgaard
Journal:  BMC Pregnancy Childbirth       Date:  2009-02-26       Impact factor: 3.007

7.  Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial.

Authors:  Corine M Koopmans; Denise Bijlenga; Jan G Aarnoudse; Erik van Beek; Dick J Bekedam; Paul P van den Berg; Jan M Burggraaff; Erwin Birnie; Kitty W M Bloemenkamp; Addi P Drogtrop; Arie Franx; Christianne J M de Groot; Anjoke J M Huisjes; Anneke Kwee; Saskia le Cessie; Aren J van Loon; Ben W J Mol; Joris A M van der Post; Frans J M E Roumen; Hubertina C J Scheepers; Marc E A Spaanderman; Rob H Stigter; Christine Willekes; Maria G van Pampus
Journal:  BMC Pregnancy Childbirth       Date:  2007-07-27       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.